Electroencephalography Devices Market Size, Share, and Industry Analysis, By Type (Portable, Standalone, and Wearable), By Product Type (EEG Equipment and EEG Accessories), By Modality (Routine EEG, Ambulatory EEG, Video-monitored EEG, and Others), By Application (Disease Diagnosis, Neurological Monitoring, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

The global electroencephalography devices market size was valued at USD 1.50 billion in 2025. The market is projected to grow from USD 1.67 billion in 2026 to USD 4.04 billion by 2034, exhibiting a CAGR of 11.66% during the forecast period.

The electroencephalography devices market is witnessing significant growth due to the technological advancements in electroencephalography devices (EEG), which are allowing for precise diagnosis of neurological disorders, including epilepsy, Parkinson’s disease, and other conditions such as sleep apnea and narcolepsy. This is expected to drive the demand for such devices to monitor the electrical activity in the brain spontaneously.

• For instance, in October 2024, Neurotech, LLC mentioned that recent technological advancements have significantly improved EEG devices by making routine procedures more efficient and enabling expanded continuous monitoring. These innovations have increased accessibility, accuracy, and convenience for patients while enhancing diagnostic capabilities for clinicians.

Electroencephalography Devices Market Driver

Rising Incidence of Neurological Disorders to Propel Market Growth

Over the past few years, there has been an increase in the incidence of neurological disorders such as epilepsy, Alzheimer’s disease, brain tumors, and Parkinson’s disease, which has significantly driven the demand for electroencephalography (EEG) devices. These conditions necessitate continuous monitoring and early diagnosis, for which EEG is a preferred non-invasive diagnostic tool. Additionally, the growing aging population is contributing to the surge in risk of such disorders, thereby driving the demand for advanced EEG systems in clinical and research settings. Such a scenario is anticipated to fuel the market growth in the forthcoming years.

• For instance, according to the data published by the World Health Organization (WHO) in March 2024, over 3.0 million individuals globally are living with some neurological conditions.

Prevalence of Parkinson's disease (million) in the U.S., by 2025 and 2030

As of July 2025, the data by Parkinson's Foundation mentioned that there are an estimated 1.1 million individuals in the U.S. living with Parkinson's disease (PD), and this figure is projected to rise to 1.2 million by 2030.

Electroencephalography Devices Market Restraint

High Cost of Advanced Electroencephalography Systems to Hinder the Market Growth

Despite the technological innovations that have improved EEG device functionality, they have also escalated the cost of acquisition, maintenance, and skilled operation. Advanced EEG machines, especially those integrated with AI-based analytics and wireless capabilities, are prohibitively hampering their adoption among smaller clinics and facilities in emerging countries. Additionally, reimbursement limitations in certain countries are limiting healthcare facilities from adopting these devices. These financial constraints are expected to hinder market expansion over the forecast period.

• For instance, as of July 2025, LabX mentioned that new EEG and EMG systems generally range from USD 20,000 to USD 150,000, depending on the features, number of channels, and complexity.

Electroencephalography Devices Market Opportunity

Integration of EEG with Wearable and Home Monitoring Solutions to Offer Lucrative Growth Opportunity

In recent years, integrating EEG technology into wearable and portable devices has opened up new market opportunities, enabling real-time brain monitoring outside of traditional clinical settings to offer applications in mental health management, sleep analysis, and even brain-computer interface (BCI) development. Moreover, the rise of telemedicine and digital health platforms is propelling the demand for user-friendly, remote EEG systems. As a result, companies are investing in wireless, AI-integrated EEG solutions to enhance their product reputation. This shift toward home-based neuro-monitoring is expected to enhance patient convenience and compliance, expanding the consumer base beyond hospitals, providing a lucrative growth opportunity for the market.

• For instance, according to the article published by Springer Nature Limited in May 2022, a group of researchers from Sungkyunkwan University, South Korea, developed a wireless earbud-like electroencephalography (EEG) measurement device. This device combined tattoo-like electrodes and connectors, enabling continuous recording of high-quality EEG signals. 

Key Insights

The report covers the following key insights:

• Incidence of Key Conditions, By Key Countries/Region, 2024
• Key Industry Developments – (Mergers, Acquisitions & Partnerships, etc.)
• New Product Launch/Approvals, By Key Players
• Technological Advancements in Electroencephalography Devices

Segmentation

Analysis by Type

By type, the market is divided into portable, standalone, and wearable.

The portable segment is expected to account for the largest market share during the forecast period. The growth is attributed to increasing approvals of portable EEG headsets by regulatory to offer convenience and a comfortable experience outside of traditional clinical settings. These increasing product approvals are anticipated to increase product diversification and availability globally, boosting the segment’s growth in the forthcoming years.

• For instance, in June 2024, the FDA granted 510(k) clearance for Zeto’s Adjustable ONE Headset for EEG brain monitoring. This product featured artificial intelligence-enabled notifications, soft-tip electrodes, and cloud integration for remote monitoring of EEG.

Analysis by Product Type

By product type, the market is divided into EEG equipment and EEG accessories.

The EEG equipment segment is expected to hold a major share during the projection period. The growth is attributed to electroencephalography (EEG) equipment advancements, enhancing its features and patient outcomes. This is increasing their adoption among the healthcare settings, streamlining the diagnosis and monitoring processes.

• For instance, according to the article by Neurotech, LLC, in October 2024, modern EEG devices have evolved significantly in recent years, expanding continuous monitoring capabilities. Moreover, researchers are focusing on refining AI applications in data interpretation and developing devices offering clinicians real-time feedback.

Analysis by Modality

By modality, the market is divided into routine EEG, ambulatory EEG, video-monitored EEG, and others.

The video-monitored EEG segment is expected to hold a major share during the projection period. The growth is attributed to rising preference for Video-monitored encephalography devices, as it is offering significant advantages over traditional EEG for diagnosing and managing seizure disorders. This is further leading to improved treatment planning to control the condition better. As a result, an increasing number of healthcare providers are adopting video-monitored EEG, which is influencing key players to launch advanced video-monitored EEG solutions.

• For instance, in April 2023, Cadwell Industries Inc. launched Arc Voyager, a remote monitoring solution with video for wireless In-Home EEG, allowing physicians to remotely access real-time EEG data and video from patients at home.

Analysis by Application

By application, the market is divided into disease diagnosis, neurological monitoring, and others.

The disease diagnosis segment is expected to hold a major share during the projection period. The growth is attributed to the increasing number of neurological disease cases, such as brain tumors, epilepsy, brain trauma, and others, which is driving the demand for effective and non-invasive disease diagnostic solutions. Electroencephalography devices are helping diagnose brain tumors by detecting abnormal brain activity, particularly in cases where tumors may be associated with neurological symptoms, thereby increasing demand.

• For instance, according to the data published by the American Cancer Society, Inc., around 24,820 malignant tumors of the brain or spinal cord were projected to be diagnosed in 2025.

Analysis by End-user

By end-user, the market is divided into hospitals & clinics, diagnostic centers, and others. 

The hospitals & clinics segment held the largest market share in 2024. The growth is attributed to the increasing number of neurology hospitals, in turn demanding the installation and implementation of effective brain activity monitoring solutions, such as electroencephalography devices. This is further expected to influence key players to increase the supply of their advanced products to increase their penetration across these settings.

• For instance, in June 2025, KEM hospital launched the Comprehensive Department of Neurosciences as a one-stop hub for neurological, mental, and neurosurgical care. 

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization   to gain extensive market insights.

North America held the largest global electroencephalography devices market share in 2024. The growth is driven by high healthcare spending, contributing to the adoption of advanced diagnostic solutions such as electroencephalography devices. Moreover, the favorable reimbursement policies for non-invasive monitoring in epilepsy and brain injury are also expected to spur the utilization of electroencephalography devices in the region.

• For instance, ambulatory electroencephalography (EEG) in the U.S. is described by CPT codes 95812, 95813, 95816, 95819, or 95822 by Medicare, which favors the reimbursement for neurological disorder monitoring in the U.S.

Asia Pacific is expected to grow at the highest CAGR in the forthcoming years. The growth is due to rising healthcare investments in response to a large patient population and increasing awareness of neurological health. As a result, countries such as China, India, and Japan are investing heavily in neurology research and expanding their hospital infrastructure. This is expected to favor the adoption of advanced diagnostic and monitoring solutions such as EEG equipment.

Key Players Covered

The global electroencephalography devices market is fragmented, with several companies offering advanced equipment and accessories. Additionally, these companies are expanding their product portfolio through strategic launches and signing collaboration agreements to enhance their market reach.

The report includes the profiles of the following key players:

• Natus Medical, Inc. (U.S.)
• Medtronic (Ireland)
• Nihon Kohden Corporation (Japan)
• Brain Products GmbH (Germany)
• Neurosoft (Russia)
• Compumedics Limited (Australia)
• Mitsar Co., LTD. (Russia)
• Micromed (Italy)
• Cadwell Laboratories, Inc. (U.S.)

Key Industry Developments

• In May 2025, Natus Medical, Inc. launched BrainWatch, a point-of-care EEG solution for deployment in both the emergency room and the ICU.
• In April 2024, Soterix Medical Inc. launchedMxN-GO EEG, a combined high definition transcranial electrical stimulation (HD-tES) and electroencephalography (EEG) system for research applications requiring electrical stimulation.